David J. Blanchard

Array ( [id] => 5514252 [patent_doc_number] => 20090214558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'NOVEL MAdCAM ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/429154 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20653 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214558.pdf [firstpage_image] =>[orig_patent_app_number] => 12429154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495358 [patent_doc_number] => 20090263386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'HUMANIZED IMMUNOMODULATORY MONOCLONAL ANTIBODIES FOR THE TREATMENT OF NEOPLASTIC DISEASE OR IMMUNODEFICIENCY' [patent_app_type] => utility [patent_app_number] => 12/406492 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 32197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263386.pdf [firstpage_image] =>[orig_patent_app_number] => 12406492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551822 [patent_doc_number] => 20090285808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'ANTI-CD19 ANTIBODIES AND USES IN ONCOLOGY' [patent_app_type] => utility [patent_app_number] => 12/401310 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 62443 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285808.pdf [firstpage_image] =>[orig_patent_app_number] => 12401310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196351 [patent_doc_number] => 07635767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same' [patent_app_type] => utility [patent_app_number] => 12/359801 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30138 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635767.pdf [firstpage_image] =>[orig_patent_app_number] => 12359801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432612 [patent_doc_number] => 07968688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Antibodies that bind to the C35 polypeptide' [patent_app_type] => utility [patent_app_number] => 12/350937 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 45 [patent_no_of_words] => 137314 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968688.pdf [firstpage_image] =>[orig_patent_app_number] => 12350937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461555 [patent_doc_number] => 07879990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Polynucleotides encoding antibodies that bind to the C35 polypeptide' [patent_app_type] => utility [patent_app_number] => 12/350944 [patent_app_country] => US [patent_app_date] => 2009-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 45 [patent_no_of_words] => 137475 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879990.pdf [firstpage_image] =>[orig_patent_app_number] => 12350944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4487640 [patent_doc_number] => 07884198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria' [patent_app_type] => utility [patent_app_number] => 12/317718 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16384 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884198.pdf [firstpage_image] =>[orig_patent_app_number] => 12317718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6232318 [patent_doc_number] => 20100184958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'MONOCLONAL ANTIBODY CAPABLE OF BINDING TO HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR' [patent_app_type] => utility [patent_app_number] => 12/329946 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 34328 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184958.pdf [firstpage_image] =>[orig_patent_app_number] => 12329946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545288 [patent_doc_number] => 20090155165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'ANTI-IGF-I RECEPTOR ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/276586 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17360 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155165.pdf [firstpage_image] =>[orig_patent_app_number] => 12276586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501596 [patent_doc_number] => 20090162284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'ANTI-IGF-I RECEPTOR ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/251884 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17362 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162284.pdf [firstpage_image] =>[orig_patent_app_number] => 12251884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355663 [patent_doc_number] => 20090187007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'ANTI-HER2 ANTIBODY VARIANTS' [patent_app_type] => utility [patent_app_number] => 12/237009 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30911 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20090187007.pdf [firstpage_image] =>[orig_patent_app_number] => 12237009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272115 [patent_doc_number] => 20090075891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Methods and dressings for sealing internal injuries' [patent_app_type] => utility [patent_app_number] => 12/222277 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21461 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075891.pdf [firstpage_image] =>[orig_patent_app_number] => 12222277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289992 [patent_doc_number] => 20090022722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD59' [patent_app_type] => utility [patent_app_number] => 12/220362 [patent_app_country] => US [patent_app_date] => 2008-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17495 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022722.pdf [firstpage_image] =>[orig_patent_app_number] => 12220362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539231 [patent_doc_number] => 20090221036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'RECOMBINANT ANTI-CD4 ANTIBODIES FOR HUMAN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/166902 [patent_app_country] => US [patent_app_date] => 2008-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22228 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221036.pdf [firstpage_image] =>[orig_patent_app_number] => 12166902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440962 [patent_doc_number] => 20090092601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'HUMANIZED ANTI-LT-beta-R ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/165276 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10827 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092601.pdf [firstpage_image] =>[orig_patent_app_number] => 12165276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297343 [patent_doc_number] => 20090012269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/165588 [patent_app_country] => US [patent_app_date] => 2008-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 40155 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012269.pdf [firstpage_image] =>[orig_patent_app_number] => 12165588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5345277 [patent_doc_number] => 20090000638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'COMPOSITION FOR THE PERMANENT SHAPING OF HUMAN HAIR' [patent_app_type] => utility [patent_app_number] => 12/145206 [patent_app_country] => US [patent_app_date] => 2008-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4095 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0000/20090000638.pdf [firstpage_image] =>[orig_patent_app_number] => 12145206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860615 [patent_doc_number] => 20080269465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'BIOLOGICAL PRODUCTS' [patent_app_type] => utility [patent_app_number] => 12/141667 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16701 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269465.pdf [firstpage_image] =>[orig_patent_app_number] => 12141667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354686 [patent_doc_number] => 20090186030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'ANTIBODIES THAT BIND BOTH BCMA AND TACI' [patent_app_type] => utility [patent_app_number] => 12/136660 [patent_app_country] => US [patent_app_date] => 2008-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22782 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186030.pdf [firstpage_image] =>[orig_patent_app_number] => 12136660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852005 [patent_doc_number] => 20080317747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/116660 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41153 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317747.pdf [firstpage_image] =>[orig_patent_app_number] => 12116660 [rel_patent_id] =>[rel_patent_doc_number] =>)